Inhibitory effects of four isoabrins on the growth of sarcoma 180 cells.
The four isoabrins were shown to be capable of inhibiting the growth of tumor cells in vivo when one-fifth of their median lethal dose was used. From the in vitro experiments, the doses required for 50% inhibition of protein biosynthesis are 3.2 pg, 45 ng, 32 ng, and 10 ng/ml for abrin-a, -b, -3, and -d, respectively. Except for abrin-b, a good correlation between the inhibitory effects of abrins on the tumor growth and protein biosynthesis was observed. These isoabrins show a moderate inhibitory effect on DNA biosynthesis.
D000036:Abrin / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D010940:Plant Proteins / Q000627:therapeutic use*; D012513:Sarcoma, Experimental / Q000188:drug therapy*
D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D010940:Plant Proteins; D000036:Abrin